These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17591872)

  • 1. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice.
    Fujita S; Saika S; Kao WW; Fujita K; Miyamoto T; Ikeda K; Nakajima Y; Ohnishi Y
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3051-5. PubMed ID: 17591872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired angiogenic response in the corneas of mice lacking osteopontin.
    Fujita N; Fujita S; Okada Y; Fujita K; Kitano A; Yamanaka O; Miyamoto T; Kon S; Uede T; Rittling SR; Denhardt DT; Saika S
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):790-4. PubMed ID: 19741245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired angiogenic response in the cornea of mice lacking tenascin C.
    Sumioka T; Fujita N; Kitano A; Okada Y; Saika S
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2462-7. PubMed ID: 21087965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
    Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fibroblast activation proteins in corneal stromal neovascularization.
    Wang T; Shi W
    Curr Eye Res; 2009 Feb; 34(2):112-7. PubMed ID: 19219682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
    Lu P; Li L; Liu G; Zhang X; Mukaida N
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
    Zuo L; Fan Y; Wang F; Gu Q; Xu X
    Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets in vitro.
    Kanayama S; Nishida K; Yamato M; Hayashi R; Sugiyama H; Soma T; Maeda N; Okano T; Tano Y
    Exp Eye Res; 2007 Dec; 85(6):772-81. PubMed ID: 17904552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization.
    Mwaikambo BR; Sennlaub F; Ong H; Chemtob S; Hardy P
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4356-64. PubMed ID: 17003426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
    Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
    Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin suppression of ocular surface inflammatory reaction.
    Kitano A; Saika S; Yamanaka O; Ikeda K; Okada Y; Shirai K; Reinach PS
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5013-22. PubMed ID: 17962452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization.
    Lu P; Li L; Liu G; Baba T; Ishida Y; Nosaka M; Kondo T; Zhang X; Mukaida N
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3516-26. PubMed ID: 22570350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkali-induced corneal neovascularization is independent of CXCR2-mediated neutrophil infiltration.
    Lu P; Li L; Mukaida N; Zhang X
    Cornea; 2007 Feb; 26(2):199-206. PubMed ID: 17251813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role for CD1d-reactive invariant natural killer T cells in cauterization-induced corneal inflammation.
    Oshima T; Sonoda KH; Nakao S; Hijioka K; Taniguchi M; Ishibashi T
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):105-12. PubMed ID: 18172081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
    Bian F; Zhang MC; Zhu Y
    Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha.
    Stannard AK; Khurana R; Evans IM; Sofra V; Holmes DI; Zachary I
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):494-502. PubMed ID: 17170373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.